Telix Pharmaceutical Ltd (TLX) Hedge Fund Ownership (Q2 2026)

Telix Pharmaceutical Ltd (TLX)

62 + Investors. Track Smart Money conviction in TLX. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — TLX

Based on 63 hedge funds · latest filing: 2026 Q2 · updated quarterly

📈

Buying streak — 1 quarter in a row

last 6Q

For 1 consecutive quarter, more hedge funds added TLX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

🏔️

At the ownership peak (100% of max)

100% of all-time peak

63 hedge funds hold TLX right now — the highest count in 2.5 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.

🚀

Fast accumulation — +200% more funds vs a year ago

fund count last 6Q

+42 new funds entered over the past year (+200% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.

🟢

More buyers than sellers — 84% buying

47 buying9 selling

Last quarter: 47 funds were net buyers (27 opened a brand new position + 20 added to an existing one). Only 9 were sellers (7 trimmed + 2 sold completely). A clear majority buying is a strong confirmation signal.

📈

More new buyers each quarter (+15 vs last Q)

new funds entering per quarter

Funds opening a new TLX position: 13 → 16 → 12 → 27. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.

🔄

Mostly new holders — 71% entered in last year

■ 2% conviction (2yr+) ■ 27% medium ■ 71% new

Only 1 funds (2%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

💰

Value +52% but shares only +27% — price-driven

Value

+52%

+26%

Last quarter: the total dollar value of institutional holdings rose +52%, but actual share count only changed +27%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.

📈

Growing discovery — still being found

16 → 13 → 16 → 12 → 27 new funds/Q

New funds entering each quarter: 13 → 16 → 12 → 27. A growing number of institutions are discovering TLX each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.

🌱

Early stage — 92% of holders entered in last year

■ 2% veterans ■ 6% 1-2yr ■ 92% new

Of 63 current holders: 58 (92%) entered in the past year, only 1 (2%) are 2+ year veterans. This is an early-phase institutional idea — still being discovered. High upside potential if the thesis plays out, but thin conviction base.

✅

Strong quality — 32% AUM from major funds

32% from top-100 AUM funds

12 of 62 holders rank in the top 100 by AUM, accounting for 32% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

6.3

out of 10

Moderate Exit Risk

Exit risk score 6.3/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q2)	Prior (2026 Q1)	Change
Funds Holding	62	38	63.16%
13F Shares	3M	3M	26.73%
Total Value	$36M	$24M	52.25%
New Positions	27	12	+15
Increased Positions	20	16	+4
Closed Positions	2	13	-11
Reduced Positions	7	8	-1
Total Calls	0	0	-
Total Puts	0	0	-
PUT/CALL Ratio	0.0	0.0	Bullish

Metric

All 13F Filers (2026 Q2)

Prior (2026 Q1)

Change

Funds Holding

63.16%

13F Shares

26.73%

Total Value

$36M

$24M

52.25%

New Positions

+15

Increased Positions

Closed Positions

-11

Reduced Positions

-1

Total Calls

Total Puts

PUT/CALL Ratio

0.0

Bullish

Institutional Holders (2026 Q2)

62 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in TLX. Verified SEC 13F-HR filings.

QUARTER:

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 25 TLX holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	Portland Investment Counsel INC.	0.86%	266,200	$3.1M
2	XY Capital Ltd	0.79%	71,291	$822K
3	Hennion & Walsh Asset Management, Inc.	0.05%	150,138	$1.7M
4	Capricorn Fund Managers Ltd	0.03%	36,100	$416K
5	NLB Skladi, upravljanje premozenja, d.o.o.	0.03%	58,000	$669K
6	Raiffeisen Bank International AG	0.02%	115,000	$1.3M
7	Portolan Capital Management, LLC	0.01%	25,424	$293K
8	Private Advisor Group, LLC	0.01%	197,250	$2.3M
9	XTX Topco Ltd	0.01%	68,776	$793K
10	Quadrature Capital Ltd	0.01%	102,425	$1.2M
11	SummitTX Capital, L.P.	0.01%	31,621	$365K
12	Integrated Wealth Concepts LLC	0.01%	164,397	$1.9M
13	Gts Securities LLC	0.01%	35,537	$410K
14	IHT Wealth Management, LLC	0.01%	32,295	$372K
15	Lazard Asset Management LLC	0.00%	284,207	$3.3M
16	Blair William & Co/Il	0.00%	122,985	$1.4M
17	Aspect Partners, LLC	0.00%	401	$5K
18	Marshall Wace, LLP	0.00%	189,188	$2.2M
19	Orion Porfolio Solutions, LLC	0.00%	15,618	$180K
20	Vident Advisory, LLC	0.00%	11,955	$138K
21	Basecamp Wealth Advisors LLC	0.00%	390	$4K
22	Hrt Financial LP	0.00%	25,637	$295K
23	Natixis	0.00%	10,999	$127K
24	Silver Grove Financial Group, Inc.	0.00%	78	—
25	Mariner, LLC	0.00%	37,085	$428K

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — Telix Pharmaceutical Ltd (TLX)

What does the Smart Money Trend signal show for TLX?

Buying streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds added TLX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for TLX?

More buyers than sellers — 84% buying: Last quarter: 47 funds were net buyers (27 opened a brand new position + 20 added to an existing one). Only 9 were sellers (7 trimmed + 2 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for TLX holders?

Strong quality — 32% AUM from major funds: 12 of 62 holders rank in the top 100 by AUM, accounting for 32% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held TLX?

Mostly new holders — 71% entered in last year: Only 1 funds (2%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

Telix Pharmaceutical Ltd (TLX)

Smart Money Signals — TLX

Buying streak — 1 quarter in a row

At the ownership peak (100% of max)

Fast accumulation — +200% more funds vs a year ago

More buyers than sellers — 84% buying

More new buyers each quarter (+15 vs last Q)

Mostly new holders — 71% entered in last year

Value +52% but shares only +27% — price-driven

Growing discovery — still being found

Early stage — 92% of holders entered in last year

Strong quality — 32% AUM from major funds

Institutional Sentiment Summary — TLX

Hedge Fund Ownership: TLX

Market Analysis: TLX

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: TLX

Hedge Fund Positioning: TLX

Statistics: TLX

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q2)

Frequently Asked Questions — Telix Pharmaceutical Ltd (TLX)

Welcome to 13Foresight!